All Bacteria articles – Page 97
-
NewsResearchers identify genetic ‘fingerprint’ to predict drug resistance in bacteria
To avoid antibiotic overuse and allow precise bacterial infection treatment, particularly against bacteria with multidrug resistance, a diagnostic tool was developed that identifies the pattern of DNA repair deficiencies acting as the bacterial antibiotic resistance ‘fingerprint’.
-
NewsTB or not TB? A new clinician decision support tool for tuberculosis
A risk assessing tool was recently developed to evaluate the likelihood of tuberculosis (TB) infections using previous patient data with or without TB. Such clinical decision support tool would allow safer and more efficient patient deisolation procedures and ensure smoother clinician workflows.
-
NewsCould faecal microbiota transplantation help patients heal after stem cell transplantation?
A study, from a part of an ongoing clinical trial, has reported the safety of oral faecal microbiota transplantation (FMT) to help patients recover from the loss of gut microbiome after allogeneic stem cell transplantation for blood cancers.
-
NewsMicrobial therapy offers new hope for vitiligo patients
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new pre-clinical study in mice.
-
NewsOral microbiome may affect cognitive function as we age
The microbial ecosystems within our mouths may affect our cognitive function as we age, according to a study. Interventions such as prebiotics, including dietary nitrate, have potential for delaying cognitive decline.
-
NewsCARB-X funds Rhode Island Hospital to assess feasibility of direct from blood detection of bacterial pneumonia
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award Rhode Island Hospital at Brown University Health US$1M to demonstrate proof-of-concept of a polymerase chain reaction (PCR) approach informed by RNA sequencing to detect bacterial pneumonia directly from whole blood.
-
NewsNew study uncovers mechanisms of bacterial dormancy involving protein aggregation
Researchers have revealed a mechanism involving protein aggregation that allows bacteria to enter a dormant state, a phenomenon that is associated with the persistence of infections and the challenge of antibiotic resistance.
-
OpinionReproductive biology though the lens of the microbiome
Madangchanok Imchen and Seth R. Bordenstein from the One Health Microbiome Center - winner of AMI’s WH Pierce Prize 2024 - explore the potential of the reproductive microbiome, particularly the fascinating Wolbachia, to counter global disease threats.
-
NewsResearchers develop new weapon against harmful algal blooms
Few studies have looked into how algal biomass, especially cyanobacteria, can be used to create materials that remove phosphate from water. Now, researchers have transformed cyanobacterial biomass, which is typically a hazardous waste, into custom-made adsorbent materials that can pull harmful phosphorus out of water.
-
NewsBacteria found to eat forever chemicals — and even some of their toxic byproducts
A new study shows that a strain taken from contaminated soil breaks apart the strong carbon-fluorine bonds of PFAS, as well as some of the shorter-chain PFAS left behind.
-
NewsTailored guidelines and reduced stigma needed to tackle leprosy, Irish case study reveals
A case report on an adult with an imported case of leprosy in Ireland shows that there are notable challenges in tackling the disease in settings where it is rare. The affected individual was one of five individuals with leprosy reported in Ireland in the past decade.
-
NewsNovel nanoreactor CU@G - AMPs: A promising solution for antibacterial therapy
A novel sustainable antibacterial therapy - an antibiotic-free complex, Cu@G-AMPs, has been developed by a team of Chinese scientists to combat drug-resistant bacteria such as MRSA.
-
NewsV-161: A breakthrough in the fight against antibiotic-resistant VRE infections
Researchers from Japan have identified V-161, a compound that inhibits Enterococcus hirae V-ATPase activity, disrupting Na+ transport and effectively inhibiting VRE growth.
-
CareersSummer placement: Fleur uncovers the world of Cutibacterium acnes and biofilms
Fleur Thorogood (20), from Cheltenham, reveals what happened during her Applied Microbiology International-sponsored Summer Placement at Cardiff University investigating Cutibacterium acnes host adaptation with respect to biofilms.
-
NewsNew study reveals how a ‘non-industrialized’ style diet can reduce risk of chronic disease
Researchers have found that a newly developed diet inspired by the eating habits of non-industrialised societies can significantly reduce the risk of a number of chronic diseases – and are to share recipes with the public. Source: UCC Jens Walter, a University College Cork Professor and a PI ...
-
NewsCuriosity-driven experiment helps unravel antibiotic-resistance mystery
An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow bacteria to build resistance to drugs.
-
NewsLooking to Kenya’s Lake Victoria for what may come for Lake Erie
Scientists conducted a genetic survey on cyanobacteria in the Winam Gulf of Kenya’s Lake Victoria, which serves as a model for the cyanobacterial harmful algal blooms (cyanHABs) in Lake Erie under the warming climate.
-
NewsShip sliming study could enable lower costs and emissions in ocean transport
A model was recently developed to find out the correlation between the speed and extent of biofilm growth and the shear stress of the ship hull. Thus, it helps save fuel consumption by preventing fluid friction from slime fouling.
-
NewsWhat microbes tell us about Nonalcoholic Fatty Liver Disease
Using medical data from more than 1,200 people, specific microbiome signatures have been identified that allow precise prediction of Nonalcoholic Fatty Liver Disease (NAFLD).
-
NewsResearch using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials
A promising research study in treating high mortality late-stage cancers with a non-toxic bacterial therapy - BacID - has proven to be safe and more targeted. The newly developed treatment would undergo clinical trials with cancer patients in 2027.